Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, United States
Scott F Rusin
Department of Cell Biology, Harvard University School of Medicine, Boston, United States
J Alan Maschek
Diabetes & Metabolism Research Center, Salt Lake City, United States; Department of Nutrition and Integrative Physiology, Salt Lake City, United States; Metabolomics, Proteomics and Mass Spectrometry Core Research Facilities University of Utah, Salt Lake City, United States
Claire L Bensard
Department of Biochemistry, Salt Lake City, United States
Sarah Fogarty
Department of Biochemistry, Salt Lake City, United States; Howard Hughes Medical Institute, Salt Lake City, United States
Mi-Young Jeong
Department of Biochemistry, Salt Lake City, United States
Sandra Lettlova
Department of Biochemistry, Salt Lake City, United States
Jordan A Berg
Department of Biochemistry, Salt Lake City, United States
Jeffrey T Morgan
Department of Biochemistry, Salt Lake City, United States; Howard Hughes Medical Institute, Salt Lake City, United States
Yeyun Ouyang
Department of Biochemistry, Salt Lake City, United States
Bradley C Naylor
Metabolomics, Proteomics and Mass Spectrometry Core Research Facilities University of Utah, Salt Lake City, United States
Joao A Paulo
Department of Cell Biology, Harvard University School of Medicine, Boston, United States
Katsuhiko Funai
Diabetes & Metabolism Research Center, Salt Lake City, United States
James E Cox
Department of Biochemistry, Salt Lake City, United States; Diabetes & Metabolism Research Center, Salt Lake City, United States; Metabolomics, Proteomics and Mass Spectrometry Core Research Facilities University of Utah, Salt Lake City, United States
Steven P Gygi
Department of Cell Biology, Harvard University School of Medicine, Boston, United States
Department of Biochemistry, Salt Lake City, United States; Diabetes & Metabolism Research Center, Salt Lake City, United States; Department of Internal Medicine, Salt Lake City, United States
Ralph J DeBerardinis
Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, United States; Howard Hughes Medical Institute, Salt Lake City, United States
Department of Biochemistry, Salt Lake City, United States; Diabetes & Metabolism Research Center, Salt Lake City, United States; Howard Hughes Medical Institute, Salt Lake City, United States
Cells harbor two systems for fatty acid synthesis, one in the cytoplasm (catalyzed by fatty acid synthase, FASN) and one in the mitochondria (mtFAS). In contrast to FASN, mtFAS is poorly characterized, especially in higher eukaryotes, with the major product(s), metabolic roles, and cellular function(s) being essentially unknown. Here we show that hypomorphic mtFAS mutant mouse skeletal myoblast cell lines display a severe loss of electron transport chain (ETC) complexes and exhibit compensatory metabolic activities including reductive carboxylation. This effect on ETC complexes appears to be independent of protein lipoylation, the best characterized function of mtFAS, as mutants lacking lipoylation have an intact ETC. Finally, mtFAS impairment blocks the differentiation of skeletal myoblasts in vitro. Together, these data suggest that ETC activity in mammals is profoundly controlled by mtFAS function, thereby connecting anabolic fatty acid synthesis with the oxidation of carbon fuels.